Location: New York, NY
CIK: 0001539436 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 16, 2016
Total Value: $1.001B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| CDNS | CADENCE DESIGN SYSTEM INC | 12,249,571 | $289M | 28.8% | $23.58 * | $18.50 | +13.2% | COM | 127387108 |
| — | MATTRESS FIRM HLDG CORP | 3,663,547 | $155M | 15.5% | $42.39 | $42.45 | — | COM | 57722W106 |
| — | COLUMBIA PPTY TR INC | 5,329,468 | $117M | 11.7% | $21.99 | $24.58 | — | COM NEW | 198287203 |
| — | RUBICON PROJ INC | 4,416,000 | $80.72M | 8.1% | $18.28 | $16.21 | — | COM | 78112V102 |
| — | ALLERGAN PLC | 247,677 | $66.39M | 6.6% | $268.03 | $297.56 | — | SHS | G0177J108 |
| AWI | ARMSTRONG WORLD INDS INC NEW | 1,166,134 | $56.41M | 5.6% | $48.37 * | $41.29 | -7.6% | COM | 04247X102 |
| — | GCP APPLIED TECHNOLOGIES INC | 2,531,097 | $50.47M | 5.0% | $19.94 | $19.94 | — | COM | 36164Y101 |
| PCRX | PACIRA PHARMACEUTICALS INC | 807,650 | $42.79M | 4.3% | $52.98 * | $77.71 | -24.7% | COM | 695127100 |
| — | GRACE W R & CO DEL NEW | 555,562 | $39.55M | 3.9% | $71.18 | $97.59 | — | COM | 38388F108 |
| — | VALEANT PHARMACEUTICALS INTL | 920,157 | $24.2M | 2.4% | $26.30 | $93.87 | — | COM | 91911K102 |
| SABR | SABRE CORP | 806,515 | $23.32M | 2.3% | $28.92 * | $23.20 | +14.9% | COM | 78573M104 |
| PFE | PFIZER INC | 688,495 | $20.41M | 2.0% | $29.64 * | $20.48 | -8.8% | COM | 717081103 |
| PTC | PTC INC | 493,029 | $16.35M | 1.6% | $33.16 * | $34.59 | -10.7% | COM | 69370C100 |
| MCK | MCKESSON CORP | 100,000 | $15.72M | 1.6% | $157.25 * | $202.49 | -26.1% | Call | 58155Q103 |
| — | VALEANT PHARMACEUTICALS INTL | 143,500 | $3.774M | 0.4% | $26.30 | $93.87 | — | Call | 91911K102 |